2. Шишкова В.Н. Весенний сезон острых респираторных инфекций: что это означает для коморбидного пациента и как к нему подготовиться. Лечебное дело. 2019; 4: 122–128. [Shishkova V.N. Spring season of acute respiratory infections: what does it mean for comorbid patient and how to prepare for it. Lechebnoe delo = General Medicine. 2019; 4: 122–128 (In Russ.)].doi: 10.24411/2071-5315-2019-12166. EDN: NOYXDP.

3. Stormorken E., Jason L.A., Kirkevold M. From good health to illness with post-infectious fatigue syndrome: a qualitative study of adults’ experiences of the illness trajectory. BMC Fam Pract. 2017; 18(1): 49–52. doi: 10.1186/s12875-017-0614-4.

4. Wang D., Hu B., Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. doi: 10.1001/jama.2020.1585

5. Stavem K., Ghanima W., Olsen M.K. et al. Prevalence and Determinants of Fatigue after COVID-19 in Non-Hospitalized Subjects: A Population-Based Study. Int J Environ Res Public Health. 2021; 18(4): 2030. doi: 10.3390/ijerph18042030

6. Callis A., Magnan de Bornier B., Serrano J.J. et al. Activity of citrulline malate on acid-base balance and blood ammonia and amino acid levels. Study in the animal and in man. Arzneimittelforschung 1991; 41(6): 660-63.

7. Емельянов В.В., Максимова Н.Е., Мочульская Н.Н. Биохимия: учебное пособие. Екатеринбург: Издательство Уральского университета. 2016; 132 с. [Emelyanov V.V., Maksimova N.E., Mochulskaya N.N. Biochemistry: textbook. Yekaterinburg: Ural University Press. 2016; 132 pp. (In Russ.)]. ISBN: 978-5-7996-1893-3.

8. Bendahan D., Mattei J.P., Ghattas B. et al. Citrulline/malate promotes aerobic energy production in human exercising muscle. Br J Sports Med. 2002; 36(4): 282-9. doi: 10.1136/bjsm.36.4.282

9. Orea-Tejeda A., Orozco-Gutierrez J.J., Castillo Martinez L. et al. The effect of L-arginine and citrulline on endothelial function in patients in heart failure with preserved ejection fraction. Cardiol J. 2010; 17(5): 464-70.

10. Торшин И.Ю., Громова О.А., Федотова Л.Э. с соавт. Хемореактомный анализ молекул цитруллина и малата. Неврология, нейропсихиатрия, психосоматика. 2017; 2: 30–35. [Torshin I.Yu., Gromova O.A., Fedotova L.E. et al. CHEMOREACTOMIC Analysis of citrulline malate molecules. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2017; 2: 30–35(In Russ.)]. doi: 10.14412/2074-2711-2017-2-30-35. EDN: ZHRQCH.5

11. Yabuki Y., Shioda N., Yamamoto Y. et al. Oral L-citrulline administration improves memory deficits following transient brain ischemia through cerebrovascular protection. Brain Res. 2013; 1520: 157-67. doi: 10.1016/j.brainres.2013.05.011.

12. Lameu C., Trujillo C.A., Schwindt T.T. et al. Interactions between the NO-citrulline cycle and brain-derived neurotrophic factor in differentiation of neural stem cells. J Biol Chem. 2012; 287(35): 29690-701. doi: 10.1074/jbc.M111.338095.

13. Glenn J.M., Gray M., Jensen A. et al. Acute citrulline-malate supplementation improves maximal strength and anaerobic power in female, masters athletes tennis players. Eur J Sport Sci. 2016;16(8): 1095-103. doi: 10.1080/17461391.2016.1158321.

14. Cunniffe B., Papageorgiou M., O’Brien B. et al. Acute citrulline-malate supplementation and high-intensity cycling performance. J Strength Cond Res. 2016; 30(9): 2638-47. doi: 10.1519/JSC.0000000000001338

15. Дубницкая Э.Б. Стимол при астенических состояниях в специализированной и общемедицинской практике (обзор литературы). Психиатрия и психофармакотерапия. 2010; 4: 12–14. [Dubnitskaya E.B. Stimol in asthenic conditions in specialized and general medical practice (literature review). Psikhiatriya i psikhofarmakoterapiya = Psychiatry and Psychopharmacotherapy. 2010; 4: 12–14 (In Russ.)]. EDN: NDGHFP.

16. Киселева А.Л. Стимол при астенических состояниях у детей. Практика педиатра. 2012; 4: 63–67. [Kiseleva A.L. Stimol for asthenic conditions in children. Praktika pediatra = Pediatric Practice. 2012; 4: 63–67 (In Russ.)]. EDN: TMCIIZ.

17. Вейн А.М., Окнин В.Ю., Федотова А.В. Применение малата цитруллина (стимола) у лиц с вегетативной дистонией в сочетании с артериальной гипотензией. Журнал неврологии и психиатрии им. С.С. Корсакова. 1999; 1: 30–33. [Wayne A.M., Oknin V.Yu., Fedotova A.V. The use of citrulline malate (stimol) in patients with vegetative dystonia in combination with arterial hypotension. 1999; 1: 30–33 (In Russ.)].

18. Balderas-Munoz K., Castillo-Martinez L., Orea Tejeda A. et al. Improvement of ventricular function in systolic heart failure patients with oral L-citrulline supplementation. Cardiol J. 2012; 19(6): 612-17. doi: 10.5603/cj.2012.0113.

19. Иванов Д.Д., Кушниренко С.В. Применение стимола в детской нефрологии: коррекция метаболических нарушений при тубулопатиях, хронической почечной недостаточности, гломерулонефрите, пиелонефрите и тубуло интерстициальном нефрите у детей. Современная педиатрия. 2011; 5: 195. [Ivanov D.D., Kushnirenko S.V. Application of Stimol in pediatric nephrology: metabolic disorders correction at tubulopathy, chronic renal failure, glomerulonephritis, pyelonephritis and tubulointerstitial nephritis in children. Sovremennaya pediatriya = Modern Pediatrics. 2011; 5: 195 (In Russ.)]. EDN: TTLEYR.

20. Громова О.А., Захарова И.Н., Торшин И.Ю. с соавт. О патофизиологической терапии астении у детей препаратами цитруллина малата. Медицинский совет. 2017; 19: 142–48. [Gromova O.A., Zakharova I.N., Torshin I.Yu. et al. About pathophysiological therapy of asthenia in children by citrulline malate drugs. Meditsinskiy sovet – Medical Council. 2017; 19: 142–48 (In Russ.)].doi: 10.21518/2079-701X-2017-19-142-148. EDN: ZQTKZT.

21. Cusumano Z.T., Watson M.E. Jr, Caparon M.G. Streptococcus pyogenes arginine and citrulline catabolism promotes infection and modulates innate immunity. Infect Immun. 2014; 82(1): 233-42. doi: 10.1128/IAI.00916-13.

22. Lin I.C., Hsu C.N., Lo M.H. et al. Low urinary citrulline/arginine ratio associated with blood pressure abnormalities and arterial stiff ness in childhood chronic kidney disease. J Am Soc Hypertens. 2016; 10(2): 115-23. doi: 10.1016/j.jash.2015.11.008.

23. Hafner P., Bonati U., Rubino D. et al. Treatment with L-citrul line and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial. Trials. 2016; 17(1): 389. doi: 10.1186/s13063-016-1503-1.

24. Giannesini B., Izquierdo M., Le Fur Y. et al. Beneficial effects of citrulline malate on skeletal muscle function in endotoxemic rat. Eur J Pharmacol. 2009; 602(1): 143-47. doi: 10.1016/j.ejphar.2008.11.015.

25. Giannesini B., Le Fur Y., Cozzone P.J. et al. Citrulline malate supplementation increases muscle efficiency in rat skeletal muscle. Eur J Pharmacol. 2011; 667(1-3): 100-4. doi: 10.1016/j.ejphar.2011.05.068.